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Convective and adsorptive removal of b2-microglobulin during
predilutional and postdilutional hemofiltration.
Background. Beta2-microglobulin (b2-m) removal in pa-
tients with end-stage renal disease (ESRD) is maximal with
convective techniques, such as hemofiltration (HF) or hemodi-
afiltration (HDF). Although the infusion mode of the re-
placement solution (predilution or postdilution) is expected to
influence the efficiency of HF, experimental data in this respect
are scanty. We therefore investigated the impact of the fluid re-
infusion mode on the efficiency of HF in 11 ESRD patients who
underwent both treatments.
Methods. The dialyzer (AK 200 ULTRA) was equipped
with a 3-layer polyamide membrane (Poliflux 21 S, surface
2.1 m2) and blood flow was kept between 300 and 400 mL/min.
b2-m concentrations were measured in plasma water and ul-
trafiltrate at appropriate times during a 240-minute treat-
ment. The following dialytic parameters were calculated: total
amount of b2-m removed (Atot), b2-m removed by convec-
tion (Acon) and by adsorption (Aads), percent reduction in
b2-m plasma water concentration (% Cpwin), total plasma wa-
ter clearance (CLpwtot), convective plasma water clearance
(CLpwcon), adsorptive plasma water clearance (CLpwads), and
sieving coefficient (SC).
Results. CLpwtot, CLpwads, and% Cpwin were similar in pre-
and postdilutional conditions, whereas CLpwcon and SC were
higher and CLpwads was lower in postdilution than in predilu-
tion HF. Since a significant inverse correlation was found be-
tween Aads and SC, predilution probably determines greater
protein fouling than postdilution.
Conclusion. The 2 techniques appear to be equivalent in
terms of total b2-m removal, although this final result is ob-
tained by different contributions of convective and adsorptive
elimination.
Beta2-microglobulin (b2-m) is a low-molecular-weight
protein that is almost exclusively eliminated by glomeru-
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lar filtration and accumulates in the plasma of patients
with end-stage renal disease (ESRD) [1]. The persistently
high b2-m plasma levels during long-term dialytic ther-
apy are thought to play a pathogenetic role in amyloid de-
position in the osteo-articular system and related clinical
signs (carpal tunnel syndrome, peripheral osteoarthropa-
thy) [2, 3]. The ability to remove b2-m varies considerably
among the available dialysis techniques, being negligi-
ble with low-flux hemodialysis (HD), intermediate with
high-flux HD, and greatest with techniques employing
convective transport, such as hemodiafiltration (HDF)
[4]. Although no renal replacement treatment proved
to normalize b2-m plasma levels [4], it is noteworthy
that ESRD patients undergoing convective procedures
have a 42% reduction of risk for carpal tunnel syndrome
surgery, compared with those submitted to diffusive pro-
cedures (HD) [5]. Accordingly, it seems logical to keep
b2-m plasma concentrations as low as possible by means
of the most suitable renal replacement therapy. By using
convective transport techniques, the efficiency of solute
removal chiefly depends on the membrane characteristics
and the infusion site (before or after the filter). Mem-
brane composition, structure, and thickness determine
the relative amount of b2-m removed by convection or
adsorption [6–8]; the 2 alternative infusion modes offer
different potential advantages and drawbacks [9–12]. In-
vestigations comparing b2-m removal in pre- and post-
dilution modes have mainly been carried out using the
convective-diffusive HDF technique [13–15]. Little in-
formation exists on this issue concerning the pure con-
vective HF technique [16]. The main aim of our study
was to evaluate the b2-m kinetics in postdilution as well
as in predilution hemofiltration. As a secondary aim, we
analyzed the single separate effects of both convection
and adsorption by the dialysis membrane on the b2-m
overall removal. The study was planned as an in vivo
study in order to take into account the effect of the
plasma proteins and, consequently, the protein-cake on
both the components, convective and adsorptive, of b2-m
removal.
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Table 1. Patient demographic and clinical characteristics (N = 11)
Sex 4 F; 7 M
Age years 66.8 ± 11.9 (46–86) a
Weight kg 64.1 ± 9.4 (45–82) a
Time on dialysis months 80.9 ± 66.9 (14–242) a
Renal disease Glomerulonephritis (N = 3)
Polycystic disease (N = 1)
Nephroangiosclerosis (N = 4)
Interstitial nephritis (N = 2)
End-stage renal disease (N = 1)
aRange.
METHODS
Patients and HF set-up
Eleven uremic patients (7 males, 4 females, mean age
67 ± 12 years, weighing 64 ± 9 kg) who had been on pe-
riodical renal replacement therapy for at least 3 months
entered this study after providing their informed consent.
The study was approved by the local Ethics Committee
and was conducted in compliance with the principles of
the Declaration of Helsinki. The inclusion criteria were
age>18 years and permanent blood access granting a flow
rate of at least 300 mL/min. The exclusion criteria were
the occurrence of severe vascular instability during treat-
ment, active HBV or HCV hepatitis, HIV positivity, coag-
ulation disorders, and neoplasms. Patients’ demographic
and clinical characteristics are listed in Table 1.
Each patient underwent 2 online hemofiltration treat-
ments, 1 in predilution (pre-HF) and 1 in postdilu-
tion mode (post-HF). The dialyzer (AK 200 ULTRA;
Gambro, Lund, Sweden) was equipped with a 3-layer
polyamide membrane (Poliflux 21 S, surface 2.1 m2) and
with a system that prepared sterile substitution solution
online. A reverse-bi-osmosis system was used for the
treatment of the main tap water. The incoming reverse-
osmosis-treated water is filtered in a polyamide ultrafilter
before entering the dialysis monitor. The infusion solu-
tion is then prepared on-line by the AK200 ULTRA, as
a sterile, nonpyrogenic solution, by stepwise ultrafiltra-
tion of water and bicarbonate-containing dialysis fluid
(BiCart), thanks to 2 polyamide ultrafilters sterilizing wa-
ter, the first inserted into the machine, the second, dispos-
able, inserted in the infusion line.
Blood flow was kept between 300 and 400 mL/min.
The exchange volume was ≈45% and ≈100% of the body
weight in post-HF and pre-HF, respectively. Previous and
hitherto unpublished observations of ours have shown
that these exchange volumes could guarantee an equiva-
lence in the urea removal.
The main treatment parameters are shown in Table 2.
Hematocrit (Hct), total plasma protein, plasma urea,
and creatinine concentrations were measured at the start
and at end of each treatment; their values are listed in
Table 3.
Table 2. Treatment parameters
Predilution Postdilution
HF HF P
Fluid replacement L 61.3 ± 15.7 25.6 ± 3.5 <0.001
Body weight decrease kg 2.9 ± 0.6 3.0 ± 0.6 NS
Blood flow (Qb) mL/min 317.3 ± 18.49 338.2 ± 26.4 <0.05
Ultrafiltration rate (Quf)
mL/min
273.7 ± 56.4 121.4 ± 14.9 <0.001
Infusion rate (Qinf)
mL/min
262.9 ± 56.1 109.0 ± 15.0 <0.001
Treatment duration minutes 240 ± 8 240 ± 3 NS
b2-microglobulin concentration measurements
The b2-microglobulin (b2-m) plasma concentrations
entering the hemofilter (Cpin) have been determined im-
mediately before starting HF (time 0) and after 30, 60,
120, 180, and 240 minutes. In pre-HF mode, blood sam-
ples were taken before dilution with replacement fluid.
The sampling times for the b2-m concentrations in plasma
leaving the hemofilter (Cpout) and in the ultrafiltrate (Cuf)
were the same except for the first time, which was 5 min-
utes instead of 0 minutes (when Cpout and Cuf are pre-
sumed to be zero). In post-HF mode, Cpout was measured
before dilution with replacement fluid.
b2-m concentrations were assayed by means of a tur-
bidimetric method using rabbit antihuman b2-m for ag-
glutination (Cobas Mira, Roche, Rotkrenz, Switzerland).
Pharmacokinetic analysis
The time courses of Cpin, Cpout, and Cuf were empiri-
cally described by cubic spline curves. The area under the
curve (AUC) of b2-m concentrations versus time (0–4 h)
was calculated for CPin (AUCpin), CPout (AUCpout), and
Cuf (AUCuf) by means of the trapezoidal rule.
Mass transfer and clearance calculations
The total amount of b2-m removed from plasma dur-
ing the 4-hour HF period (Atot) was calculated by the
formula:
Atot = (AUCbin − AUCbout) × Qb (Equation 1 )
where AUCbin is the AUC of b2-m concentrations in the
blood entering the hemofilter, AUCbout is the AUC of
b2-m concentrations in the blood leaving it, and Qb is
blood flow. Since b2-m is distributed outside red cells,
b2-m blood concentrations (Cb) can be calculated by us-
ing the b2-m plasma concentration (Cp) and the hemat-
ocrit value expressed as a decimal fraction (Hct):
Cb = Cp × (1 − Hct) (Equation 2)
The Hct of the blood entering the hemofilter (Hctin)
was directly measured, and that leaving it (Hctout) were
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Table 3. Hematochemical parameters at start and end of HF
Start End
Hct Proteins Urea Creat Hct Proteins Urea Creat
% g/dL mg/dL mg/dL % g/dL mg/dL mg/dL
Pre-HF 32.7 ± 4.3 6.40 ± 0.66 145.1 ± 30.0 8.91 ± 1.78 36.6b ± 5.0 7.43a ± 0.84 59.4b ± 19.6 3.88b ± 1.15
Post- HF 32.7 ± 3.5 6.57 ± 0.56 135.6 ± 49.0 8.30 ± 1.74 35.9a ± 4.7 7.28a ± 0.87 61.3b ± 21.3 3.45b ± 1.03
aP < 001; bP < 0.0001.
calculated from Hctin, Qb, and the input/output fluid
balance, according to the following formulas:
for predilutional HF : Hctout = (Qb × Hctin)/
(Qb − Quf + Qinf)
(Equation 3)
for postdilutional HF : Hctout = (Qb × Hctin)/
(Qb − Quf)
(Equation 4)
where Quf is the ultrafiltration flow and Qinf is the infu-
sion rate. (See Appendix for calculations yielding Equa-
tions 3 and 4).
The amount of b2-m removed by convection [i.e., re-
covered in the ultrafiltrate during the 4-hour HF period
(Acon)], was calculated by the formula:
Acon = AUCuf × Quf (Equation 5)
The amount of b2-m removed by membrane adsorp-
tion (Aads) was calculated as the difference between Atot
and Acon.
The mean dialytic b2-m plasma water clearances for
total, convective, and adsorptive removal were calculated
using Atot, Acon, and Aads, respectively:
CLpwtot = Atot/AUCpwin (Equation 6)
CLpwcon = Acon/AUCpwin (Equation 7)
CLpwcon = Aads/AUCpwin (Equation 8)
where AUCpwin is the AUC of b2-m plasma water con-
centrations entering the hemofilter (Cpwin). Cpwin was
obtained from Cpin and the total plasma protein concen-
tration (Pt) using Colton’s formula [17]:
Cpwin = Cpin/(1 − 0.0107 × Pt) (Equation 9)
where the Pt unit is g/dL.
To investigate possible time-dependent changes in
b2-m clearances, CLpwtot, CLpwto, CLpwtot were also
determined at each sampling interval (0–0.5, 0.5–1, 1–2,
2–3, 3–4 hours).
As an additional index of b2-m removal, the percent-
age difference between Cpwin measured at the end and
start of HF (% Cpwin) was calculated.
The sieving coefficient was calculated for convec-
tive b2-m removal as the ratio between measured
CLpwcon and maximal theoretical plasma water clearance
(CLpwmax, i.e., the CLpw expected if S = 1), which are:
for postdilutional HF CLpwmax = Quf;
(Equation 10)
for predilutional HF CLpwmax = Qpw × Quf/
(Qpw + Qinf)
(Equation 11)
where Qpw is mean the plasma water flow during the
4-hour HF period. Qpw was calculated from the mean
plasma flow [=Qb× (1−Hctmean)] corrected by the mean
plasma protein concentration:
Qpw = Qb × (1 − Hctmean) × (1 − 0.0107 × Ptmean)
(Equation 12)
Statistical analysis
Data are reported as mean ± SD. Comparisons be-
tween HF parameters measured in pre-HF and post-HF
conditions were carried out by means of Student t test
for paired data or the Wilcoxon paired rank test (for not
normally distributed data). Time-related differences in
fractional clearances and sieving coefficients were tested
by means of a one-way analysis of variance (ANOVA) for
repeated measures, followed by the Newman-Keuls post-
hoc test. Correlations between parameters were assessed
by linear regression analysis and the determination co-
efficient (r2). The level of significance was considered as
P < 0.05.
RESULTS
The urea and creatinine reduction ratios were 59 ±
11% and 56 ± 10%, respectively, in pre-HF, and 54 ± 7%
and 58 ± 10% in post-HF, with the differences between
the 2 modes not being significant.
The time courses of the mean b2-m concentrations in
the plasma (Cpin, Cpout) and the ultrafiltrate (Cuf), after
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Fig. 1. Time courses of mean b2-m concentrations in plasma (Cpin,
Cpout) and ultrafiltrate (Cuf).
Table 4. Model-independent pharmacokinetic parameters of b2-m
based on Cpin, Cpout, and Cuf
Predilution Postdilution
(N = 11) (N = 11) P
Cp0 mg/L 31.7 ± 10.7 30.4 ± 6.8 NS
Cp4h mg/L 9.8 ± 5.1 7.7 ± 3.3 NS
AUCpin mg/L · min 3705 ± 1556 3074 ± 945 NS
AUCpout mg/L · min 2463 ± 1160 4191 ± 1174 <0.0005
AUCuf mg/L · min 907 ± 471 2090 ± 656 <0.0001
both pre- and postdilution modes are shown in Figure 1.
No significant differences between pre- and postdilution
were found for pharmacokinetic parameters Cp0, Cp4h,
and AUCpin, but AUCpout and AUCuf were higher in
post-HF than in pre-HF (Table 4). As expected, Hct and
Pt increased, and urea and creatinine plasma concentra-
tions decreased from the start to the end of each proce-
dure (Table 3).
The parameters characterizing the ultrafiltration pro-
cess with the 2 techniques are listed in Table 5. CLtot
was slightly but not significantly (P = 0.064) higher dur-
ing post-HF. By contrast, CLcon and CLads significantly
differed between the 2 techniques [i.e., CLcon was signif-
Table 5. Mean values ± SD of the main parameters of HF efficiency
Predilution Postdilution
(N = 11) (N = 11) P
Plasma water clearance mL/min
CLmax 114.5 ± 14.1 121.3 ± 14.9 NS
CLtot 73.4 ± 12.4 82.8 ± 12.5 NS
CLcon 60.8 ± 13.1 79.6∗ ± 11.8 <0.005
CLads 12.6 ± 9.3 3.2∗ ± 8.3 <0.005
Sieving coefficient 0.53 ± 0.10 0.65∗ ± 0.07 <0.005
% Cpwin −70.5 ± 7.4 −74.7 ± 6.6 NS
b2-microglobulin removal mg
Atot 288.9 ± 113.8 273.2 ± 77.6 NS
Acon 236.6 ± 93.9 260.5 ± 65.1 NS
Aads 52.3 ± 40.0 12.7∗ ± 28.6 <0.005
icantly higher (79.6 mL/min vs. 60.8 mL/min) and CLads
was significantly lower (3.2 mL/min vs. 12.6 mL/min)
in post-HF than in pre-HF]. The same trend was ob-
served for the amounts of b2-m removed (Atot, Acon,
Aads), although only Aads was significantly lower in post-
HF than in pre-HF (52.3 mg vs. 12.7 mg). Using pooled
pre- and post-HF data, a significant inverse correlation
(r2 = 0.43; P = 0.0009) was found between the amount of
b2-m adsorbed by the membrane (Aads) and the sieving
coefficient.
The percentage decrease in Cpwin from the start to
the end of the treatment was similar (−70.5% in pre-
HF vs. −74.6% in post-HF). The sieving coefficient was
significantly higher in post- than in predilution (0.65 vs.
0.55).
The changes in CLpwtot, CLpwcon, CLpwads, and siev-
ing coefficient throughout the 4-hour HF period are
shown in Figures 2 and 3. The one-way ANOVA re-
vealed that CLpwtot, CLpwcon underwent a significant
time-dependent decrease in both HF modes, whereas
CLpwads decreased only with post-HF and the sieving
coefficient decreased only with pre-HF (Table 6).
DISCUSSION
Different strategies have been adopted in the course
of time in order to prevent the accumulation of b2-m.
The routine use of polyacrylonitrile or, more in general,
the switch from conventional to high-flux dialysis mem-
branes have proven to be useful to reduce the risk of
carpal tunnel syndrome [18]. The bacteriologic control
of all the dialysis fluids, avoiding the endotoxin contam-
ination, may also play a preventative role. In actual fact,
some studies have demonstrated that the use of high-
quality dialysis fluids alone may reduce the incidence of
carpal tunnel syndrome [19, 20]. The use of convective
dialysis therapies, in addition to the control of the bio-
compatibility aspects of dialysis, may add the strength
of an enhanced removal, to the reduced production of
b2-m, thus resulting to be the best strategy to prevent
b2-m–related pathologies.
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Fig. 2. Changes in fractional CLpwtot, CLpwcon and CLpwabs during
HF procedure. Columns labeled with same letter differ significantly
(post-hoc test).
The main result of our study is that the overall HF
efficiency in removing b2-m from plasma, evaluated as
CLpwtot, Atot, and% Cpwin, is similar in both pre- and
postdilutional conditions. These findings are in contrast
with what is generally stated in the literature (i.e., that
the removal of middle molecules is higher in predilution
modes) [21–24]. However, another recent study [15] re-
ported no substantial differences between pre- and post-
dilution HDF in regards to the total amount of b2-m
removed from plasma.
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Fig. 3. Changes in sieving coefficient during HF procedure. Columns
labeled with same letter differ significantly (post-hoc test).
Table 6. Influence of time on HF parameters
Predilution HF Postdilution HF
CLpwtot P < 0.0001 P < 0.005
CLpwcon P < 0.005 P < 0.05
CLpwads NS P < 0.005
Sieving coefficient P < 0.005 NS
One-way ANOVA.
After a more in-depth analysis of removal mechanisms,
it appears that the equivalence of CLpwtot arises from
balanced, opposite changes in convective and adsorp-
tive clearances with the 2 techniques, as testified by the
higher CLpwcon and lower CLpwads values found in post-
HF in comparison with pre-HF. The former was almost
entirely attributable to a higher sieving coefficient (0.65
vs. 0.55), as CLpwmax was virtually the same in both
infusion modes (114 mL/min vs. 121 mL/min). In line
with this finding, we have recently observed [25] that,
at equivalent transmembrane pressure, the loss of albu-
min through the dialysis membrane is greater in post-HF
than in pre-HF. In this respect, it is noteworthy that the
sieving coefficient was similar at the beginning of the 2
procedures and then significantly decreased only during
pre-HF treatment (Fig. 3). Therefore, the sieving coeffi-
cient may change during HF depending on the technique
used. Interestingly, using pooled data, a significant in-
verse correlation was found between the amount of b2-m
adsorbed to the membrane (Aads) and the sieving coef-
ficient. If we accept that b2-m adsorption is a marker
of the more general phenomenon of protein deposition
on the filter surface, we could conclude that the reduced
convective b2-m removal in predilution is due to greater
protein fouling. This finding contrasts with the intuitive
notion that plasma and blood concentrations occurring
during post-HF should reduce HF efficiency by increasing
blood viscosity and clogging the membrane pores. How-
ever, ultrafiltration is a process ruled by several factors
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[10, 12], whose analysis may provide explanations. To jus-
tify the greater Aads found with pre-HF than with post-
HF, it may be assumed that the true adsorbing surface
is different with the 2 techniques, even though the same
hemofilter is used. As membrane pores are structured
like water channels rather than simple holes, they proba-
bly oppose differing degrees of hydraulic resistance. If so,
the higher ultrafiltration flow used in pre-HF may open
a greater number of channels, thus increasing the actual
membrane surface and the amount of b2-m adsorbed.
Regarding the differences in sieving efficiency, it is
known that the sieving coefficient is not constant for any
given solute-membrane combination, but depends on the
blood and the ultrafiltration flows. The high blood flows
used in predilution (true Qb + Qinf) are expected to
increase the wall shear rate and decrease the solute po-
larization (i.e., the rise in b2-m concentration at the mem-
brane surface that improves the sieving coefficient) [10,
21]. Solute polarization is considered to be particularly
important for macromolecules, like b2-m, which are con-
fined to plasma water and accumulate on the membrane
surface more than small molecules. Indeed, experimental
data indicate that, if Qb is gradually increased in post-
HF while Quf is kept constant, the sieving coefficient for
b2-m first increases (for Qb up to 450–500 mL/min) and
then decreases [10]. Furthermore, it has been shown that,
if Quf is increased in constant Qb conditions, the b2-m
sieving coefficient uniformly decreases [10]. Therefore,
on the whole, the high blood flow and ultrafiltrate rate
typical of pre-HF tend to reduce the sieving coefficient
for b2-m.
CONCLUSION
Our data show a substantial equivalence between pre-
HF and post-HF in removing b2-m from plasma, although
the contribution of convective and adsorptive mecha-
nisms is different in the 2 techniques. In the long term,
predilution HF could prove more useful in patients with
high hematocrit levels. This is a frequent condition today
in view of the routine use of erythropoetin to maintain
the hemoglobin levels within an ideal range (11–12 g/dL),
and may favor the clotting of the hemofilter in the post-
dilution modality.
Since the efficiency of urea and creatinine removal,
measured as percent decreases in baseline plasma con-
centrations, is also comparable, the choice between the
2 HF modes should be solely based on feasibility and
economic assessment.
APPENDIX
Hctout may be calculated using the formula:
Hctout = Qe/Qbout (Equation a)
where Qe is erythrocyte flow through the hemofilter and Qbout is blood
flow leaving the hemofilter. Qe is equal to
Qbin × Hctin (Equation b)
Qbout depends on the amount of fluid infused and/or lost and on the
HF technique:
Qbout = Qbin − Quf + Qinf, for predilutional HF (Equation c)
Qbout = Qbin − Quf, for postdilutional HF (Equation d)
Substituting Qe and Qbout in Eq. a for Eqs. b, c, and d yields Eqs. 3 and
4 (see Methods).
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